BPA Call HT001420A0025-HT001421F0192
Award Date
9/28/21
Potential Completion Date
9/27/22
Potential Value
$45K
Federal Agency
Defense Health Agency
Awardee
Ark Diagnostics, Inc.
Ultimate Awardee
Not listed
NAICS Category
325413 - In-Vitro Diagnostic Substance Manufacturing
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20889, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed price Blanket Purchase Agreement (BPA) call order awarded by the Bureau of Medicine and Surgery, a Defense agency, to Ark Diagnostics, Inc. The BPA has a ceiling value of $18,015 and was awarded on December 12, 2014 with a period of performance through December 18, 2014. The award is for the delivery of ARK Diagnostics List products, which includes reagents, assay kits, and other consumable laboratory supplies used for managing drug levels. Ark Diagnostics is a for-profit...
This is a firm fixed price purchase order awarded to Ark Diagnostics, Inc. by the U.S. Army Medical Command (MEDCOM) to provide reagents and methotrexate assay kits over a five-year period from October 2023 through September 2028. The award has a total ceiling value of $338,385.54. Ark Diagnostics, Inc. is a privately held company that develops and commercializes in vitro diagnostic immunoassays. This contract was not set aside for any specific business type. Ark Diagnostics has previously...
This firm fixed price purchase order for $706,192 was awarded by the Department of the Army Medical Command to Ark Diagnostics, Inc. to supply methotrexate assay kits. The award supports the requirements outlined in the pre-solicitation notice seeking FDA-approved reagents, supplies, calibrators, controls and materials compatible with Roche analyzers at Brooke Army Medical Center and surrounding clinics. Ark Diagnostics will deliver the methotrexate assay kits under the $8 million blanket...
The Department of the Army Medical Command awarded a firm fixed price purchase order contract to Ark Diagnostics, Inc., a privately held foreign-owned manufacturer, to provide methotrexate assay kits. The $134,700.00 contract has a completion date of December 14, 2018 and was set aside for small businesses. Ark Diagnostics has supplied similar pharmaceutical testing products, including fentanyl assay kits and anesthesia apparatuses, to Department of Defense health agencies under past contract...
The Defense Health Agency, a component of the Department of Defense, awarded a $107,630 firm fixed price blanket purchase agreement call contract to Biodiscovery LLC, doing business as Daicel Arbor Biosciences. The contract is to deliver two MYBAITS-1-768-B products in support of DHA programs. Work will be performed in Ann Arbor, Michigan and runs from July 6 to July 15, 2022. No subcontractors or set aside designations were identified. DHA manages the Military Health System for over 9 million...
The Defense Health Agency (DOD) awarded Roche Diagnostics Corporation a $1.32 million firm fixed price blanket purchase agreement (BPA) call contract for monthly drop shipment of chemical monitoring services. Under this contract, Roche will provide routine delivery of chemistry testing supplies to medical treatment facilities within the DHA network located in Bethesda, Maryland. As the prime, Roche will be responsible for fulfillment through the end of February 2024 in support of the Agency's...
The Defense Health Agency (DOD) awarded Roche Diagnostics Corporation a $1,223,142.60 firm fixed price blanket purchase agreement call contract to provide reagents and testing kits. The contract will be performed in Bethesda, Maryland and has a period of performance from September 29, 2022 through February 28, 2023. Roche Diagnostics Corporation will serve as the prime contractor to supply laboratory reagents and diagnostic test kits to the Defense Health Agency in support of their medical...
Diatec-S.R.L. was awarded a $23,689 delivery order against an unspecified government-wide acquisition contract (GWAC) to provide reagents for Vitros 5600 or XT7600 laboratory equipment to the Defense Health Agency (DHA). As the military's medical support agency, DHA ensures readiness by maintaining the health of Service members and their families. This firm fixed price order has a period of performance from September 8 to October 30, 2023 to supply testing reagents, allowing DHA-supported...
This federal contract award, valued at $75,000.00, was issued by the Defense Health Agency (DHA) to Archerdx LLC, a subsidiary of Invitae Corporation. The contract is for the provision of lab supplies and assays, medical, surgical instruments, equipment, and supplies. The contract type is a Blanket Purchase Agreement (BPA) call order, with a firm fixed price pricing structure. The award is not associated with a set-aside program. Archerdx LLC has previously received federal contract awards...
The Defense Health Agency, a component of the Department of Defense, awarded a $46,932 blanket purchase agreement call contract to Zuellig Pharma Limited for the purchase of medical supplies and reagents to support the agency's Diarrhea Project in Thailand. The firm fixed price contract runs from September 22, 2023 through September 30, 2023 and calls against an existing BPA with Zuellig Pharma to deliver the requested products and services. No subcontractors or set aside designations were...